Home › Calculator › DSNKY Dividend Calculator 2026
DSNKY DRIP Calculator & Dividend Yield 2026
2.77% YieldHealthcareDaiichi Sankyo Company, Limited · OTC
Price: $17.84 · Annual div: $0.4939/share · Frequency: semi-annual · Payout ratio: N/A · Ex-div: 2026-09-30
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
DSNKY Dividend Yield
DSNKY (Daiichi Sankyo Company, Limited) has a dividend yield of 2.77%, based on an annual dividend of $0.4939 per share and a price of $17.84. Over the last 12 months it paid $0.5592 per share — a trailing yield of 3.13%. Dividends are paid semi-annual.
Yield history: over the last 12 payments, DSNKY's 12-month yield ranged from 0.70% to 3.10%. Full DSNKY dividend history ↓
Yield on cost: if DSNKY's dividend keeps growing 15.0% a year, a purchase at today's price would yield 5.57% after 5 years, 11.20% after 10 years and 45.31% after 20 years on the original investment.
DSNKY DRIP Rate: How Many Shares Your Dividends Buy
With dividends reinvested, a DSNKY position grows its share count by about 2.77% in the first year at today's price and yield.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When DSNKY pays your bills
Year your monthly dividend income covers each expense (based on current settings)
DSNKY Dividend History — Last 37 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-09-30Latest | 2026-12-10 | $0.3178 | 3.10% | $18.02 |
| 2026-03-31 | 2026-06-30 | $0.2414 | 2.64% | $18.59 |
| 2025-09-30 | 2025-12-17 | $0.2495 | 1.92% | $23.83 |
| 2025-03-31 | 2025-07-01 | $0.2068 | 1.66% | $24.25 |
| 2024-09-30 | 2024-12-17 | $0.1966 | 0.95% | $40.52 |
| 2024-03-27 | 2024-06-25 | $0.1901 | 1.30% | $33.40 |
| 2023-09-28 | 2023-12-15 | $0.1383 | 1.18% | $29.99 |
| 2023-03-30 | 2023-06-27 | $0.1061 | 0.70% | $31.12 |
| 2022-09-29 | 2022-12-08 | $0.1104 | 0.70% | $29.98 |
| 2022-03-30 | 2022-07-05 | $0.0991 | 0.94% | $23.25 |
| 2021-09-28 | 2021-12-09 | $0.1194 | 1.00% | $24.23 |
| 2021-03-29 | 2021-06-29 | $0.1221 | 0.85% | $29.47 |
| 2020-09-28 | 2020-12-08 | $0.1293 | — | — |
| 2020-03-27 | 2020-06-23 | $0.1095 | — | — |
| 2019-09-26 | 2019-12-10 | $0.1075 | — | — |
| 2019-03-28 | 2019-06-26 | $0.1075 | — | — |
| 2018-09-27 | 2018-12-10 | $0.1027 | — | — |
| 2018-03-28 | 2018-06-26 | $0.1063 | — | — |
| 2017-09-28 | 2017-12-08 | $0.1041 | — | — |
| 2017-03-28 | 2017-06-27 | $0.1046 | — | — |
| 2016-09-27 | 2016-12-08 | $0.1021 | — | — |
| 2016-03-28 | 2016-06-30 | $0.0957 | — | — |
| 2015-09-25 | 2015-12-08 | $0.1082 | — | — |
| 2015-03-26 | 2015-07-10 | $0.0806 | — | — |
| 2014-09-25 | 2014-12-15 | $0.0846 | — | — |
| 2014-03-26 | 2014-07-01 | $0.0981 | — | — |
| 2013-09-25 | 2013-12-09 | $0.0972 | — | — |
| 2013-03-26 | 2013-07-01 | $0.1023 | — | — |
| 2012-12-10 | — | $0.4578 | — | — |
| 2012-07-02 | — | $0.4740 | — | — |
| 2012-03-27 | 2012-07-02 | $0.1257 | — | — |
| 2011-09-27 | 2011-12-15 | $0.1286 | — | — |
| 2011-03-28 | 2011-07-13 | $0.1231 | — | — |
| 2010-09-27 | 2010-12-15 | $0.1185 | — | — |
| 2010-03-26 | 2010-07-14 | $0.1119 | — | — |
| 2009-09-25 | 2009-12-15 | $0.1147 | — | — |
| 2009-03-26 | 2009-07-14 | $0.1387 | — | — |
About Daiichi Sankyo Company, Limited (DSNKY) — Dividend Analysis 2026
Daiichi Sankyo Company, Limited is a global pharmaceutical enterprise that encompasses the entire lifecycle of drug development, from pioneering research and development to manufacturing, importation, marketing, and worldwide distribution of its medicinal products. Its extensive and diverse portfolio features numerous key pharmaceutical offerings: Oncology: This includes trastuzumab deruxtecan (an anti-HER2 antibody-drug conjugate for cancer treatment), gefitinib for malignant tumors, bicalutamide for prostate cancer, and tamoxifen, an anti-breast cancer agent. Cardiovascular and Metabolic Health: The company provides teneligliptin and a combination of teneligliptin/canagliflozin for managing type 2 diabetes mellitus, along with colesevelam for both hypercholesterolemia and type 2 diabetes. Other notable products in this area are prasugrel, an antiplatelet agent; edoxaban, an anticoagulant; olmesartan, an antihypertensive; and pravastatin for hypercholesterolemia. Neurology and Pain Management: Offerings include mirogabalin for pain relief, lacosamide as an anti-epileptic agent, memantine for Alzheimer's disease, and loxoprofen, an anti-inflammatory analgesic. Bone Health: Denosumab is available for conditions like osteoporosis and other bone disorders. Gastrointestinal and Other Specialized Treatments: This category features esomeprazole for ulcer treatment, silodosin for dysuria, and ferric carboxymaltose and iron sucrose injections to address anemia. Infectious Diseases and Immunology: Daiichi Sankyo markets laninamivir for anti-influenza treatment, levofloxacin as an antibacterial agent, and a range of vaccines including adsorbed cell culture-derived influenza, influenza HA, measles rubella combined, and mumps vaccines. Beyond prescription medications, the company also supplies a variety of consumer healthcare products: Over-the-Counter Remedies: Lulu, a combination cold remedy, and Loxonin S, an antipyretic/anti-inflammatory analgesic. Dermatology and Personal Care: Transino, aimed at improving melasma and treating spots/freckles; Minon skincare products; and oral care solutions like Breath Labo and Clean Dental. Furthermore, Daiichi Sankyo's operations extend to pharmaceuticals and drugs for animals, cosmetics, medical equipment, various food products, drinking water, and active pharmaceutical ingredients (APIs) and intermediates. The company is also engaged in strategic collaborations, notably with Guardant Health to develop Guardant360 CDx, a companion diagnostic specifically for Enhertu in patients with advanced metastatic non-small cell lung cancer. Established in 1899, Daiichi Sankyo Company, Limited maintains its corporate headquarters in Tokyo, Japan.
DSNKY Dividend & DRIP — Frequently Asked Questions
What is DSNKY's dividend yield?
DSNKY (Daiichi Sankyo Company, Limited) has a dividend yield of 2.77%, based on an annual dividend of $0.4939 per share and a price of $17.84. Over the last 12 months it paid $0.5592 per share — a trailing yield of 3.13%. Dividends are paid semi-annual.
How much does $10,000 in DSNKY pay in dividends?
$10,000 in DSNKY at a 2.77% yield pays about $277 a year ($23 a month) before taxes. With DRIP, reinvested dividends buy more shares and that income compounds.
What is the DRIP rate for DSNKY?
With dividends reinvested, a DSNKY position grows its share count by about 2.77% in the first year at today's price and yield.
How do I calculate DSNKY dividend reinvestment (DRIP) returns?
Enter your starting amount, monthly contribution and time horizon in the DSNKY DRIP calculator at the top of this page. It reinvests each payout into new shares at the projected price, grows the dividend at the rate you choose and shows yearly income, share count, portfolio value and yield on cost. You can switch DRIP off to compare.
When is DSNKY's next ex-dividend date?
DSNKY's next ex-dividend date has not been announced yet; the most recent one was 2026-09-30. DSNKY pays dividends semi-annual. Buy before the ex-dividend date to receive the next payment.
What is DSNKY's dividend growth rate?
DSNKY's dividend changed 22.5% over the last year and 23.9% a year on average over five years.
Similar dividend stocks to DSNKY
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full DSNKY DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open DSNKY position with:
🌍 DSNKY Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold DSNKY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2.77% | -0.03% | $277 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2.35% | -0.45% | $235 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2.22% | -0.58% | $222 / yr |
| 🇬🇧 UK ISA | 0% | 2.77% | -0.03% | $277 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2.53% | -0.27% | $253 / yr |
| 🇨🇦 TFSA | 0% | 2.77% | -0.03% | $277 / yr |
| 🇨🇦 CA Taxable | 25% | 2.08% | -0.72% | $208 / yr |
| 🇦🇺 Super (pension) | 15% | 2.35% | -0.45% | $235 / yr |
| 🇦🇺 AU Taxable | 30% | 1.94% | -0.86% | $194 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2.04% | -0.76% | $204 / yr |
| 🇫🇷 FR Taxable | 30% | 1.94% | -0.86% | $194 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 DSNKY Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.49/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 DSNKY Dividend Payment Schedule
DSNKY pays quarterly — 4 times per year. Ex-div: 2026-09-30.
📊 DSNKY vs Healthcare Benchmarks
How DSNKY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for DSNKY sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ DSNKY Insider Activity
No recent SEC filings reported in the last 90 days.Peer Group
Similar companies in the same sectorCompare DSNKY with peers: DSNKY vs CHALF · DSNKY vs HLNCF · DSNKY vs HOCPF
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the DSNKY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Daiichi Sankyo Company, Limited (DSNKY) is currently trading at $17.84, 33% below its 52-week high. The current dividend yield is 2.77% based on an annual payout of $0.4939 per share.
DSNKY (Daiichi Sankyo Company, Limited) — 2.77% Dividend Yield Analysis
Daiichi Sankyo Company, Limited (DSNKY) is a healthcare stock currently trading at $17.84 with a dividend yield of 2.77%. It pays an annual dividend of $0.4939 per share. Over the past 5 years, DSNKY has grown its dividend at a compound annual rate of 23.9%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest DSNKY News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
How investors use the DSNKY dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.